Sunil Healthcare (BOM:537253) Other Current Receivables: ₹0.0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:537253 Sunil Healthcare Ltd BOM:537253
58 GF Score
Price ₹70.00
GF Value ₹70.60
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Sunil Healthcare Other Current Receivables?

Sunil Healthcare BOM:537253 +1.42% 58 Other Current Receivables is ₹0.0 Mil as of Mar. 2026. GuruFocus rates BOM:537253 with a GF Score™ of 58/100 and a GF Value™ of ₹70.60 (Fairly Valued). The stock has 7 warning signs investors should review.

Sunil Healthcare's Other Current Receivables for the quarter that ended in Mar. 2026 was ₹0.0 Mil.

Sunil Healthcare's annual Other Current Receivables increased from Mar. 2024 (₹2.25 Mil) to Mar. 2025 (₹2.97 Mil) but then declined from Mar. 2025 (₹2.97 Mil) to Mar. 2026 (₹0.00 Mil).

Sunil Healthcare Other Current Receivables Related Terms

Sunil Healthcare Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Sunil Healthcare's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sunil Healthcare Other Current Receivables Chart

Sunil Healthcare Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.21 2.59 2.25 2.97 0.00

Sunil Healthcare Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.97 0.00 0.00 0.00 0.00
BOM:537253
58GF Score
Sunil Healthcare Ltd BOM:537253
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sunil Healthcare Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of ₹0.0 Mil mean?
Sunil Healthcare (BOM:537253) has a Other Current Receivables of ₹0.0 Mil as of Mar. 2026. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Sunil Healthcare and its competitors.
Is Sunil Healthcare's Other Current Receivables too high?
Sunil Healthcare's current Other Current Receivables is ₹0.0 Mil. Overall, Sunil Healthcare has a GF Score™ of 58/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sunil Healthcare's Other Current Receivables compare to ZTS?
Sunil Healthcare's Other Current Receivables of ₹0.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Drug Manufacturers company?
A good Other Current Receivables depends on the Drug Manufacturers industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Sunil Healthcare and its competitors. Sunil Healthcare's current Other Current Receivables is ₹0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sunil Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Sunil Healthcare (BOM:537253) is currently considered Fairly Valued. The stock's GF Value™ is ₹70.60, compared to a current price of ₹70.00 — trading 0.8% below its estimated fair value. The current Other Current Receivables is ₹0.0 Mil. Sunil Healthcare's overall GF Score™ is 58/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Sunil Healthcare (BOM:537253), the current Other Current Receivables is ₹0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sunil Healthcare (BOM:537253) Overvalued in 2026?

Based on GuruFocus' analysis, Sunil Healthcare stock appears to be undervalued. The current stock price of ₹70.00 is trading 0.8% below its estimated GF Value™ of ₹70.60. GuruFocus considers Sunil Healthcare to be Fairly Valued.

Key valuation signals for BOM:537253:

  • Other Current Receivables: ₹0.0 Mil
  • GF Value™: ₹70.60 vs. price of ₹70.00 (0.8% below fair value)
  • GF Score™: 58/100 with 7 warning signs

No single metric tells the full story. See the BOM:537253 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sunil Healthcare Business Description

Address 38E/252 - A, Vijay Tower, 3rd Floor, Opposite Panchsheel Commercial Complex, Shahpurjat, New Delhi, IND, 110049
Sunil Healthcare Ltd manufactures hard gelatin capsule shells that are used by pharmaceutical and food supplement companies. It operates in a single segment, that is, Empty Capsules. The company manufactures nine different sizes of capsules. Its products include BSE Free Capsules, Pearl Capsules, Liquid Fill Capsules, Stick Free Capsules, and Preservative Free Capsules. The company generates the majority of its revenue from India.
58GF Score

Get the complete analysis for BOM:537253

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹70.00
Price
₹70.60
GF Value